Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer’s Disease Differential Diagnosis
Background: Differential diagnosis of Alzheimer’s disease (AD) is a complex task due to the clinical similarity among neurodegenerative diseases. Previous studies showed the role of lipid peroxidation in early AD development. However, the clinical validation of potential specific biomarkers in minim...
Main Authors: | Carmen Peña-Bautista, Lourdes Álvarez, Thierry Durand, Claire Vigor, Ana Cuevas, Miguel Baquero, Máximo Vento, David Hervás, Consuelo Cháfer-Pericás |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/9/8/649 |
Similar Items
-
Assessment of Lipid Peroxidation in Alzheimer’s Disease Differential Diagnosis and Prognosis
by: Laura Ferré-González, et al.
Published: (2022-03-01) -
Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis
by: Carmen Peña-Bautista, et al.
Published: (2021-06-01) -
Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer’s Disease
by: Carmen Peña-Bautista, et al.
Published: (2020-05-01) -
Assessment of Screening Approach in Early and Differential Alzheimer’s Disease Diagnosis
by: Laura Ferré-González, et al.
Published: (2021-10-01) -
Plasma Lipidomics Approach in Early and Specific Alzheimer’s Disease Diagnosis
by: Carmen Peña-Bautista, et al.
Published: (2022-08-01)